Purchase Order HT001423P0115
Award Date
5/23/23
Potential Completion Date
5/31/24
Potential Value
$245K
Federal Agency
Defense Health Agency
Awardee
Immucor Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products for blood transfusion and transplantation testing. The contract, valued at $209,111.24, is for the delivery of CLIN reagents and supplies. It is a firm fixed-price Blanket Purchase Agreement (BPA) call order with a completion date of March 13, 2019. Immucor has a history of providing specialized reagents, blood analyzers, testing equipment, and related...
This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products, specifically blood typing, compatibility testing, and antibody screening reagents and consumables. The $137,483.05 contract has an ultimate completion date of December 31, 2027 and does not utilize any set-aside designations. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare...
This federal contract award, N6809622P0004, was issued by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. The $80,569.98 firm fixed-price purchase order is for the delivery of IMMUCOR REAGENTS and REAGENT SUPPLIES. This contract is not set aside for any specific business category. Immucor Inc. is a long-standing federal contractor, providing critical...
This is a federal contract award to Immucor Inc., a leading provider of automated in vitro diagnostics, reagents, and test kits for blood transfusion and transplantation compatibility testing. The contract, awarded by the Defense Health Agency, is for the delivery of blood bank reagents under a firm fixed-price, indefinite delivery contract with a ceiling value of $242,001.84 and a period of performance through September 30, 2027. The contract was awarded on September 18, 2024 and is not...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer, for the delivery of medical supplies such as fetal blood screen kits, blood cells, and PanoCell products. The potential value of the contract is $216,898.69, with a performance period through April 24, 2023. The contract does not have a set-aside designation. Immucor has previously been awarded federal contracts to provide blood banking supplies, reagents, and testing...
This is a delivery order awarded to Immucor Inc. under the Defense Health Agency's federal contract vehicle. The $17,097.60 firm fixed price order is for the supply of blood bank reagents to support the agency's blood transfusion and immunohematology testing programs. The ultimate completion date for this order is September 30, 2025. Immucor is a leading manufacturer of automated in vitro diagnostic systems and consumables for blood typing and compatibility testing used in medical facilities,...
The Defense Health Agency awarded a firm-fixed-price purchase order to Immucor Inc., a for-profit manufacturer of goods, for the delivery of blood typing reagents. The $228,353.45 contract has an ultimate completion date of September 30, 2027. Immucor has previously provided a variety of in vitro diagnostic products, reagents, test kits, and blood banking supplies to federal agencies such as the Department of Veterans Affairs and the Indian Health Service. This award is not set aside and is...
This federal contract award is for the procurement of WB CORQC BLOOD BANK REAGENTS by the Defense Health Agency (DHA), a Defense agency. The contract was awarded to Immucor Inc., a manufacturer of in vitro diagnostic products and solutions for blood transfusion and transplantation compatibility testing. The award, valued at $228,785.56, is structured as a Blanket Purchase Agreement (BPA) call with a firm fixed price. The contract does not have a set-aside designation and is expected to be...
The Department of the Army Medical Command awarded a firm fixed-price purchase order contract to Immucor Inc., a for-profit manufacturer of goods, to provide RHD BEADCHIP KIT,SLIDE 6X8. The contract is set aside for small businesses and has a potential value of $1,484,569.70. The contract has a completion date of September 30, 2022 and was originally awarded on November 21, 2017. Immucor is a leading provider of automated instrument-reagent systems and consumables for blood transfusion and...